New strategy for safer CAR T cell therapy in lymphomas
In the treatment of aggressive lymphomas and blood cancer (leukaemia), so-called chimeric antigen receptor T cells (CAR T cells) are increasingly being used. For this therapy, immune cells are taken from patients and programmed by means of genetic engineering to detect proteins on the malignant tumour cells. Back in the body, the CAR T cells then fight the cancer cells. Due to some heavy side effects, this therapy requires extreme caution and long hospital stays. Scientists at University Hospital Cologne are therefore researching new mechanisms to make CAR T cell-based immunotherapy more effective and safer. The team led by Dr Markus Chmielewski at the Center for Molecular Medicine Cologne (CMMC) is now presenting a new strategy for making CAR T cell-based immunotherapy more effective and safer. The study ‘An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL’ was published in the journal Cell Reports Medicine.
From bedside to bench
This strategy is based on the examination of tissue of patients with lymphoma who were treated in Department I of Internal Medicine at University Hospital Cologne. The research team found an increasing number of the surface proteins CD80 and CD86 on the tumour cells. Such a high number of these proteins is not found on healthy B lymphocytes (B cells), the affected cells of the immune system in lymphomas. In contrast to the previously available CAR T cell therapies, which usually only target the surface protein CD19, the researchers used two CAR constructs with different target proteins that complement each other to activate the T cells against the tumour cells. CD19 was selected as the target for the first CAR construct because it is present on all B lymphocytes. Another target is CD80/CD86, because it occurs on malignant B lymphocytes. To this end, the researchers used a binding domain, a protein sequence that can recognize and bind both CD80 and CD86 in the form of a lock-and-key principle.
Both CAR constructs work together as an 'AND' switch that only allows the CAR T cell to fully activate and fight the target cell if both surface markers are detected. This does not harm normal B cells that only possess the CD19 marker, which is the case with CAR T cell therapies approved to date. This allows normal B cells to continue their important work as part of the immune system. This also works the other way around – if only the second CAR construct binds to CD80 or CD86, but there is no CD19 binding.
“Our CAR T cells show a more differentiated and longer-lasting stimulation through the biological 'AND' switch. They fight cancer cells more effectively than previously approved CAR T cell approaches and at the same time do not harm healthy B lymphocytes and other CD19-positive cells,” said Fabian Prinz, lead author of the study and medical student in his clinical internship, summarizing the results.
From bench back to bedside
The results were achieved in the laboratory using cell cultures and also mouse models. “Our next steps for the coming years are clear: The preparation of a clinical trial and the testing of the proposed strategy in patients with B-cell lymphoma,” said Chmielewski. He summarized: “The preclinical success of our CAR T cell approach is an example of the importance of translational research that recognizes real problems of patients, translates them into scientific problems that can be addressed in the laboratory, and finds solutions through experiments.”
The study was supported by funding from the German Research Foundation (DFG) as part of the Collaborative Research Centre (CRC) 1530: Elucidation and targeting of pathogenic mechanisms in B cell malignancies.
ELSE PRESS RELEASES FROM THIS DATE:
Acting on a proposal from the Institut Pasteur President Yasmine Belkaid, the Institut Pasteur Board of Governors appointed Mariana Mesel-Lemoine as Director of Diversity, Equity and Inclusion on Wednesday February 7, 2024.
This appointment marks a significant milestone in the history of the Institut Pasteur, and it is the first French research institute to establish a position of this kind at such a senior and strategic level. Mariana Mesel-Lemoine will report directly to the President. Her mission will be to propose policy and strategy priorities related to diversity, equity and inclusion for the "Pasteur 2030" Strategic Plan, to oversee ...
About The Study: In hospitals participating in Get With The Guidelines–Stroke, earlier anticoagulation reversal was associated with improved survival for patients with intracerebral hemorrhage. These findings support intensive efforts to accelerate evaluation and treatment for patients with this devastating form of stroke.
Authors: Kevin N. Sheth, M.D., of the Yale University School of Medicine in New Haven, Connecticut, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this ...
Sleep apnea is prevalent among cardio-oncology patients who are at higher risk for congestive heart failure from cancer therapy, according to a new study being presented at the American College of Cardiology (ACC) Advancing the Cardiovascular Care of the Oncology Patient course.
Sleep apnea is a disorder of altered breathing while asleep with two types, obstructive (OSA) or central (CSA). Both can be treated to alleviate symptoms and improve cardiovascular outcomes. This study pertains to obstructive sleep apnea. A well-established screening tool for detecting sleep apnea is the STOP-BANG questionnaire utilizing eight questions using ...
Since December 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a worldwide threat. The emergence of the BA.2.86 variant, a subvariant of Omicron, has raised significant concerns due to its substantial number of mutations. Discovered in August 2023, this variant differs markedly from other existing types such as Omicron XBB (including EG.5.1 and HK.3). Compared with XBB and BA.2, BA.2.86 exhibits more than 30 mutations in its spike protein, contributing to its ability to effectively evade the immune system’s defenses.
Sensory feedback is important for amputees to be able to explore and interact with their environment. Now, researchers have developed a device that allows amputees to sense and respond to temperature by delivering thermal information from the prosthesis’ fingertip to the amputee’s residual limb. The “MiniTouch” device, presented February 9 in the journal Med, uses off-the-shelf electronics, can be integrated into commercially available prosthetic limbs, and does not require surgery. Using the thermally sensitive prosthetic hand, ...
Pisa, 9 February 2024. “When one of the researchers placed the sensor on his own body, I could feel the warmth of another person with my phantom hand. it was a very strong emotion for me, it was like reactivating a connection with someone”.
Thanks to a sensorised prosthetic hand that provides realistic and real-time thermal feedback, Fabrizio, a 57-year-old man from Pistoia with a transradial (wrist) amputation, was able to discriminate between and manually sort objects of different temperatures or materials and ...
The past year has seen major advances in Large Language Models (LLMs) such as ChatGPT. The ability of these models to interpret and produce human text sources (and other sequence data) has implications for people in many areas of human activity. A new perspective paper in the journal Neuron argues that like many professionals, neuroscientists can either benefit from partnering with these powerful tools or risk being left behind.
In their previous studies, the authors showed that important preconditions are met to develop LLMs that can interpret and analyze neuroscientific data like ChatGPT interprets language. These AI models can be built for many different types ...
About The Study: This study including 202,000 veterans with COVID-19 and 202,000 matched uninfected veterans found that outpatient use increased significantly in the month after infection, then attenuated but remained greater than the uninfected cohorts’ use through 12 months, which suggests that there are sustained impacts of COVID-19 infection.
Authors: Matthew L. Maciejewski, Ph.D., of the Durham Veterans Affairs Health Care System in Durham, North Carolina, is the corresponding author.
To access the embargoed study: Visit our For The Media ...
About The Study: The findings of this study including 133 adults with severe obesity suggest that bariatric surgery was associated with health benefits two years after surgery. Bariatric surgery was associated with improved cognition and general health and changed blood vessel efficiency and cortical thickness of the temporal cortex. These results may improve treatment options for patients with obesity and dementia.
Authors: Amanda J. Kiliaan, Ph.D., of the Radboud University Medical Center, Donders Institute for Brain, Cognition, ...
A technique can determine for the first time how frequently, and exactly where, a molecular event called “backtracking” occurs throughout the genetic material (genome) of any species, a new study shows.
Published online February 9 in Molecular Cell, the study results support the theory that backtracking represents a widespread form of gene regulation, which influences thousands of human genes, including many involved in basic life processes like cell division and development in the womb.
Led by researchers from NYU Grossman School of Medicine, the work revolves around genes, the stretches ...
LAST 30 PRESS RELEASES:
[Press-News.org] New strategy for safer CAR T cell therapy in lymphomas